Insider Transactions in Q1 2022 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,186
-2.16%
|
$0
$0.65 P/Share
|
|
Mar 31
2022
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,630
-1.52%
|
$0
$0.65 P/Share
|
|
Mar 31
2022
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,469
-1.52%
|
$0
$0.65 P/Share
|
|
Mar 31
2022
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
773
-0.48%
|
$0
$0.65 P/Share
|
|
Mar 17
2022
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
312,302
+22.55%
|
-
|
|
Mar 17
2022
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+23.95%
|
-
|
|
Mar 17
2022
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+24.68%
|
-
|
|
Mar 17
2022
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+31.6%
|
-
|